Germany’s BioNTech raises vaccine sales outlook to €12.4bn

Vaccine producer hikes sales forecast, up from nearly €10bn, as orders roll in

PODCAST | The future of healthcare in a digital world

Mudiwa Gavaza is joined by Ryan Noach, the CEO of Discovery Health

PODCAST | Medical cover shortfalls hurt consumers

Gap cover is one area that shows the need for more education

PODCAST | Why do we think we can manage Covid-19 vaccination in just one year?

Mudiwa Gavaza speaks to Dr Ernest Darkoh, a founding partner of the BroadReach Group

Netcare reports partial recovery as it eyes third-wave threat

Private hospital operator says Covid-19 weighed on first-half core profit

WATCH: How B4SA to plans to help with SA’s vaccination drive

Business for SA head Stavros Nicolaou talks to Business Day TV about getting South Africans vaccinated

Mediclinic pares recovery forecast due to third-wave threat

The private hospital operator had expected to return to prepandemic performance in 2022

Lesotho manufacturer gets green light to export cannabis to EU

MG Health has been positioned as the first manufacturer in Africa able to export medicinal cannabis to the EU

Biotech start-up Vaccitech files for US IPO

Vaccitech owns the technology behind the Covid-19 vaccine developed by Oxford and AstraZeneca

Valneva to start final vaccine trials with new shot in virus arsenal

The vaccine uses the whole, inactivated virus to create an immune response, an old but proven approach

Netcare’s multimillion-rand PPP deal collapses in Lesotho

Hospital group and government trade allegations

Ascendis warns of business rescue over restructuring

The group is battling with R6.6bn net debt burden, and an expensive debt structure, prompting recapitalization talks with lenders

WATCH: Why SA may miss the herd immunity target​

Wits University’s health & social security systems specialist, Alex van den Heever, talks to Business Day TV

University spin-off Oxford Nanopore plans to list in London

DNA sequencing group could be valued at £4bn in  UK float

BioNTech lifts vaccine target to 2.5-billion in 2021

German biotech company’s chief says the company is developing a vaccine that can be stored in a fridge and a freeze-dried version useful for stockpiling

Discovery to inoculate high-risk members when vaccine becomes available

CEO Adrian Gore says SA on the brink of securing vaccines to cover more than 37-million adults


Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.